Awaiting results for a Phase 3 study for this drug to combat cytokine storm in severe COVID-19 cases. The stock is nuts cytodyn.com/newsroom/press…

Fantastic m2m results out! P=.0223 When you consider that m2m is the hardest group to show any clinical improvement in it makes these results that much more impressive! cytodyn.com/newsroom/press…

Michael Savage Sad big-Pharma appears to be influencing the care of our President by admin drugs that have limited impacts on COVID. The science, MOA, Mild/Mod stat-sig Ph2 results and 6+ yrs safe in HIV trials of #leronlimab are being overlooked. It decreases virus, C-storm, restores immune.